vs
HEALTHEQUITY, INC.（HQY）とProgyny, Inc.（PGNY）の財務データ比較。上の社名をクリックして会社を切り替えられます
HEALTHEQUITY, INC.の直近四半期売上が大きい（$322.2M vs $318.4M、Progyny, Inc.の約1.0倍）。HEALTHEQUITY, INC.の純利益率が高く（16.0% vs 3.9%、差は12.1%）。HEALTHEQUITY, INC.の前年同期比売上増加率が高い（7.2% vs 6.7%）。HEALTHEQUITY, INC.の直近四半期フリーキャッシュフローが多い（$137.8M vs $48.6M）。過去8四半期でHEALTHEQUITY, INC.の売上複合成長率が高い（10.8% vs 7.0%）
HealthEquity, Inc.は米国のフィンテック・事業サービス企業で、米国内国歳入庁から非銀行系健康貯蓄受託者の指定を受けています。資金がどの金融機関に預けられているかにかかわらず、同社が健康貯蓄口座の管理者として業務を行うことが可能です。
Progyny, Inc.は米国を中心に事業を展開する有力な不妊治療・家族形成支援福利厚生サービスプロバイダーです。企業顧客と提携し、体外受精、妊孕性温存、養子縁組支援、代理出産サポートなどの福利厚生を提供し、多様な業種の従業員にサービスを届けています。
HQY vs PGNY — 直接比較
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $322.2M | $318.4M |
| 純利益 | $51.7M | $12.5M |
| 粗利率 | 70.8% | 24.1% |
| 営業利益率 | 24.4% | 4.8% |
| 純利益率 | 16.0% | 3.9% |
| 売上前年比 | 7.2% | 6.7% |
| 純利益前年比 | 806.4% | 18.5% |
| EPS（希薄化後） | $0.59 | $0.14 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $322.2M | $318.4M | ||
| Q3 25 | $325.8M | $313.3M | ||
| Q2 25 | $330.8M | $332.9M | ||
| Q1 25 | $311.8M | $324.0M | ||
| Q4 24 | $300.4M | $298.4M | ||
| Q3 24 | $299.9M | $286.6M | ||
| Q2 24 | $287.6M | $304.1M | ||
| Q1 24 | $262.4M | $278.1M |
| Q4 25 | $51.7M | $12.5M | ||
| Q3 25 | $59.9M | $13.9M | ||
| Q2 25 | $53.9M | $17.1M | ||
| Q1 25 | $26.4M | $15.1M | ||
| Q4 24 | $5.7M | $10.5M | ||
| Q3 24 | $35.8M | $10.4M | ||
| Q2 24 | $28.8M | $16.5M | ||
| Q1 24 | $26.4M | $16.9M |
| Q4 25 | 70.8% | 24.1% | ||
| Q3 25 | 71.4% | 23.2% | ||
| Q2 25 | 67.8% | 23.7% | ||
| Q1 25 | 60.6% | 23.4% | ||
| Q4 24 | 65.6% | 21.3% | ||
| Q3 24 | 68.0% | 20.7% | ||
| Q2 24 | 65.1% | 22.5% | ||
| Q1 24 | 63.1% | 22.4% |
| Q4 25 | 24.4% | 4.8% | ||
| Q3 25 | 27.5% | 6.9% | ||
| Q2 25 | 25.1% | 7.3% | ||
| Q1 25 | 13.5% | 7.5% | ||
| Q4 24 | 6.5% | 5.3% | ||
| Q3 24 | 19.6% | 4.3% | ||
| Q2 24 | 14.5% | 6.8% | ||
| Q1 24 | 14.8% | 6.7% |
| Q4 25 | 16.0% | 3.9% | ||
| Q3 25 | 18.4% | 4.4% | ||
| Q2 25 | 16.3% | 5.1% | ||
| Q1 25 | 8.5% | 4.6% | ||
| Q4 24 | 1.9% | 3.5% | ||
| Q3 24 | 11.9% | 3.6% | ||
| Q2 24 | 10.0% | 5.4% | ||
| Q1 24 | 10.0% | 6.1% |
| Q4 25 | $0.59 | $0.14 | ||
| Q3 25 | $0.68 | $0.15 | ||
| Q2 25 | $0.61 | $0.19 | ||
| Q1 25 | $0.30 | $0.17 | ||
| Q4 24 | $0.06 | $0.12 | ||
| Q3 24 | $0.40 | $0.11 | ||
| Q2 24 | $0.33 | $0.17 | ||
| Q1 24 | $0.30 | $0.17 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $309.3M | $112.2M |
| 総負債低いほど良い | $982.1M | — |
| 株主資本純資産 | $2.1B | $516.0M |
| 総資産 | $3.4B | $742.4M |
| 負債/資本比率低いほどレバレッジが低い | 0.46× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $309.3M | $112.2M | ||
| Q3 25 | $304.5M | $134.0M | ||
| Q2 25 | $287.9M | $132.5M | ||
| Q1 25 | $295.9M | $109.2M | ||
| Q4 24 | $322.2M | $162.3M | ||
| Q3 24 | $326.9M | $91.5M | ||
| Q2 24 | $251.2M | $95.0M | ||
| Q1 24 | $404.0M | $115.0M |
| Q4 25 | $982.1M | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $925.7M | — | ||
| Q1 24 | $875.0M | — |
| Q4 25 | $2.1B | $516.0M | ||
| Q3 25 | $2.1B | $560.0M | ||
| Q2 25 | $2.1B | $515.0M | ||
| Q1 25 | $2.1B | $467.2M | ||
| Q4 24 | $2.1B | $422.1M | ||
| Q3 24 | $2.2B | $434.9M | ||
| Q2 24 | $2.1B | $456.2M | ||
| Q1 24 | $2.0B | $571.6M |
| Q4 25 | $3.4B | $742.4M | ||
| Q3 25 | $3.4B | $795.2M | ||
| Q2 25 | $3.4B | $761.0M | ||
| Q1 25 | $3.4B | $730.3M | ||
| Q4 24 | $3.5B | $607.1M | ||
| Q3 24 | $3.5B | $660.0M | ||
| Q2 24 | $3.2B | $698.6M | ||
| Q1 24 | $3.2B | $794.3M |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.44× | — | ||
| Q1 24 | 0.43× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $138.6M | $54.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $137.8M | $48.6M |
| FCFマージンFCF / 売上 | 42.8% | 15.3% |
| 設備投資強度設備投資 / 売上 | 0.2% | 1.8% |
| キャッシュ転換率営業CF / 純利益 | 2.68× | 4.34× |
| 直近12ヶ月FCF直近4四半期 | $413.0M | $191.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $138.6M | $54.2M | ||
| Q3 25 | $135.9M | $50.7M | ||
| Q2 25 | $64.7M | $55.5M | ||
| Q1 25 | $75.7M | $49.8M | ||
| Q4 24 | $90.5M | $52.2M | ||
| Q3 24 | $108.1M | $44.5M | ||
| Q2 24 | $65.4M | $56.7M | ||
| Q1 24 | $77.1M | $25.7M |
| Q4 25 | $137.8M | $48.6M | ||
| Q3 25 | $135.1M | $46.0M | ||
| Q2 25 | $64.7M | $50.2M | ||
| Q1 25 | $75.4M | $47.0M | ||
| Q4 24 | $90.3M | $50.3M | ||
| Q3 24 | $107.4M | $42.7M | ||
| Q2 24 | $64.7M | $55.8M | ||
| Q1 24 | $76.5M | $24.9M |
| Q4 25 | 42.8% | 15.3% | ||
| Q3 25 | 41.5% | 14.7% | ||
| Q2 25 | 19.5% | 15.1% | ||
| Q1 25 | 24.2% | 14.5% | ||
| Q4 24 | 30.0% | 16.8% | ||
| Q3 24 | 35.8% | 14.9% | ||
| Q2 24 | 22.5% | 18.4% | ||
| Q1 24 | 29.2% | 8.9% |
| Q4 25 | 0.2% | 1.8% | ||
| Q3 25 | 0.2% | 1.5% | ||
| Q2 25 | 0.0% | 1.6% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 0.3% | 0.3% | ||
| Q1 24 | 0.2% | 0.3% |
| Q4 25 | 2.68× | 4.34× | ||
| Q3 25 | 2.27× | 3.65× | ||
| Q2 25 | 1.20× | 3.24× | ||
| Q1 25 | 2.87× | 3.31× | ||
| Q4 24 | 15.88× | 4.95× | ||
| Q3 24 | 3.02× | 4.27× | ||
| Q2 24 | 2.27× | 3.44× | ||
| Q1 24 | 2.92× | 1.52× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
HQY
| Financial Service Other | $159.1M | 49% |
| Services | $120.3M | 37% |
| Credit And Debit Card | $42.8M | 13% |
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
